Familial Amyloid Polyneuropathy

Common Name(s)

Familial Amyloid Polyneuropathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial Amyloid Polyneuropathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial Amyloid Polyneuropathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Familial Amyloid Polyneuropathy" returned 83 free, full-text research articles on human participants. First 3 results:

[Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina].
 

Author(s): Marcelo Chaves, Mariela Bettini, Sebastián Marciano, Soledad Sáez, Edgardo Cristiano, Marcelo Rugiero

Journal: Medicina (B Aires). 2016 ;76(2):105-8.

 

Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is a hereditary disease with variable geographical distribution. The aim of this study was to present our experience with TTR-FAP patients. We retrospectively analyzed nine cases belonging to different families. Diagnostic ...

Last Updated: 4 May 2016

Go To URL
Endoscopic Findings of Small-Bowel Lesions in Familial Amyloid Polyneuropathy: A Case Report.
 

Author(s): Kensuke Asakura, Shunichi Yanai, Shotaro Nakamura, Keisuke Kawaski, Makoto Eizuka, Kazuyuki Ishida, Tamotsu Sugai, Mitsuharu Ueda, Taro Yamashita, Yukio Ando, Takayuki Matsumoto

Journal: Medicine (Baltimore). 2016 Mar;95(11):e2896.

 

Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease associated with the mutations in the transthyretin gene. To date, the endoscopic findings of the small-bowel lesions of FAP have never been described. We report a rare case of FAP with gastrointestinal involvement. ...

Last Updated: 18 Mar 2016

Go To URL
Optimizing the management of transthyretin familial amyloid polyneuropathy in Europe: early diagnosis and effective care.
 

Author(s): David Adams,

Journal: Curr. Opin. Neurol.. 2016 Feb;29 Suppl 1():S1-2.

 

Last Updated: 22 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Familial Amyloid Polyneuropathy" returned 5 free, full-text review articles on human participants. First 3 results:

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.
 

Author(s): David Adams, Ole B Suhr, Ernst Hund, Laura Obici, Ivailo Tournev, Josep M Campistol, Michel S Slama, Bouke P Hazenberg, Teresa Coelho,

Journal: Curr. Opin. Neurol.. 2016 Feb;29 Suppl 1():S14-26.

 

Early and accurate diagnosis of transthyretin familial amyloid polyneuropathy (TTR-FAP) represents one of the major challenges faced by physicians when caring for patients with idiopathic progressive neuropathy. There is little consensus in diagnostic and management approaches across Europe.

Last Updated: 22 Jan 2016

Go To URL
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
 

Author(s): Yesim Parman, David Adams, Laura Obici, Lucía Galán, Velina Guergueltcheva, Ole B Suhr, Teresa Coelho,

Journal: Curr. Opin. Neurol.. 2016 Feb;29 Suppl 1():S3-S13.

 

Transthyretin familial amyloid polyneuropathy (TTR-FAP) is a highly disabling, life-threatening disease characterized by progressive sensorimotor and autonomic neuropathy. The profile of the disease across Europe is inadequately understood at present.

Last Updated: 22 Jan 2016

Go To URL
Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.
 

Author(s): A C Martins, A M Rosa, E Costa, C Tavares, M J Quadrado, J N Murta

Journal: Biomed Res Int. 2015 ;2015():282405.

 

This paper aims to review the morphological and functional characteristics of patients affected by familial amyloid polyneuropathy (FAP), with greater focus on type I and its progression after liver transplantation. We also analyse therapeutic options for the ophthalmic manifestations.

Last Updated: 11 Nov 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
 

Status: Available

Condition Summary: TTR-mediated Amyloidosis; Amyloidosis, Hereditary; Amyloid Neuropathies, Familial; Familial Amyloid Polyneuropathies; Amyloid Neuropathies; Amyloidosis, Hereditary, Transthyretin-Related

 

Last Updated: 29 Nov 2016

Go to URL
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
 

Status: Recruiting

Condition Summary: Transthyretin Mutations; Transthyretin Amyloidosis

 

Last Updated: 22 Nov 2016

Go to URL

Last Updated: 28 Jul 2016

Go to URL